NEW YORK (TheStreet) -- RATINGS CHANGES
was downgraded at Barclays to equal-weight from overweight. Valuation has been fully realized after 37% year-to-date gain, Barclays said.
Mellanox(MLNX) - Get Report was upgraded at Barclays to overweight from equal-weight. Tailwinds over the next 18 to 24 months include strength in the HPC industry, an upcoming server refresh cycle, data center and storage spending trends, strength in the 40G market and the eventual move to 100G, Barclays said. Twelve-month price target was raised to $57 from $50.
Priceline.com (PCLN) was downgraded at FBR Capital Markets to market perform from outperform. Twelve-month price target is $1,225. Guidance suggests that growth is decelerating, FBR Capital Markets said.
PerkinElmer(PKI) - Get Report was downgraded at Goldman Sachs to neutral from buy. Company was also cut from the Conviction list. Valuation call, based on a 12-month price target of $47, Goldman Sachs said.
Theravance (THRX) was downgraded at Leerink Partners to market perform from outperform. Twelve-month price target is $17. Survey suggests limited upside potential for Breo and Anoro, Leerink Partners said.
Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes", which is available only to Real Money subscribers. To find out how to become a subscriber, please click here.
This article was written by a staff member of TheStreet.